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Xenopusk1) protein mediates numerous cell fate decisions and morphogenetic processes.
Its carboxyl terminal cysteine-rich region (termed C1) binds LRP5/6 and inhibits canonical Wnt signaling.
Paradoxically, the isolated C1 domain of Dkk1 as well as Wnt antagonists that act by sequestering Wnts, such
as Frz-B, WIF-1 and Crescent, are poor mimics of the inductive and patterning activities of Dkk1 critical for
heart and axial development. To understand the basis for the unique properties of Dkk1, we investigated the
function of its amino terminal cysteine-rich region (N1). N1 does not bind LRP or Kremen nor inhibit Wnt
signaling and has had no known function. We show that it can synergize with BMP antagonism to induce
prechordal and axial mesoderm when expressed as an independent protein in Xenopus embryos. Moreover,
we show that it can function in trans to complement the activity of C1 protein to mediate two embryologic
functions of Dkk1: induction of chordal and prechordal mesoderm and speciﬁcation of heart tissue from non-
cardiogenic mesoderm. Remarkably, N1 also synergizes with WIF-1 and Crescent, indicating that N1 signals
independently of C1 and its interactions with LRP. Since cleavage of Dkk1 is not detected, these results deﬁne
N1 as a novel signaling domain within the intact protein that is responsible for the potent effects of Dkk1 on
the induction and patterning of the body axis and heart. We conclude that this new activity is also likely to
synergize with canonical Wnt inhibitory in the numerous developmental and disease processes that involve
Dkk1.
© 2008 Elsevier Inc. All rights reserved.IntroductionDkk1 is a potent inducer of heart development in non-cardiogenic
mesoderm, as demonstrated by the formation of ectopic hearts in
normally non-cardiogenic ventroposterior marginal zone (VMZ)
explants of Xenopus embryos (Foley and Mercola, 2005; Schneider
and Mercola, 2001), in posterior lateral plate mesoderm of chick
embryos (Marvin et al., 2001), and in embryonic stem cell (ESC)
cultures (Naito et al., 2006). Other secreted Wnt antagonists, such as
Wnt inhibitory factor-1 (WIF-1), Crescent, or Frz-B, are generally less
potent inducers, whereas intracellular inhibitors of canonical Wnt
signaling, such as GSK3β or a dominant negative version of TCF3,
initiate cardiogenesis but do not stimulate the formation of beating
heart muscle (Foley et al., 2006; Marvin et al., 2001; Schneider and
Mercola, 2001). Loss of Dkk1 function in early mouse embryos causes
anencephaly (Mukhopadhyay et al., 2001) and over-expression
studies using Xenopus and zebraﬁsh embryos (Glinka et al., 1998;
Kazanskaya and Nierhrs, 2000; Shinya et al., 2000) have conﬁrmed its
ability to induce head and anterior structures. Secondary body axes
induced by combination of BMP inhibition and Dkk1 expression
typically have ectopic heads with normally-positioned bilateral eyes,a).
l rights reserved.whereas similar expression of Frz-B, dominant negative Wnt8, or
Cerberus yields cyclopic heads (Kazanskaya and Nierhrs, 2000),
suggesting that important differences exist between these Wnt
antagonists and Dkk1. Here we investigated whether the early
developmental inductive and patterning properties of Dkk1 are due
to a novel activity that is independent of Wnt antagonism.
Dkk1 consists of conserved amino terminal (N1) and carboxy-
terminal (C1) cysteine-rich regions. Antagonism of canonical Wnt
signaling occurs through binding of C1 to LRP5/6 proteins on the
surface of the cell and subsequent disruption of the cell surface Wnt/
LRP5/6/Frizzled signaling complex (reviewed in Niehrs, 2006). Other
secretedWnt antagonists, such asWIF-1, Crescent, and Frz-B, function
by binding and sequestering secreted Wnt proteins. The signaling
properties of Wnts and Wnt antagonists have been extensively
characterized (reviewed in Logan and Nusse, 2004; Niehrs, 2006).
One difference that has emerged between Dkk1 (and Dkk2 and 4) and
other Wnt antagonists is that, by binding LRP5/6, Dkk1/2/4 could bias
signaling toward the non-canonical Wnt planar cell polarity (PCP)
pathway that involves Frizzled but not LRP receptors. Another, but not
mutually exclusive, explanation for Dkk1's distinct activity is that the
amino terminal cysteine-rich domain of Dkk1 (N1) might harbor a
new activity that could complement the canonical Wnt antagonizing
properties of C1 and trigger signaling that is required for the full
patterning and morphogenetic effects of the intact protein. N1 lacks
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signaling or biological function has been ascribed to this domain.
We found that the early embryological activity of Dkk1 indeed
requires a novel activity that resides within the N1 domain. Deletion
of the N1 domain impaired development of axial mesoderm, yet,
when expressed as independent proteins, N1 synergized with C1
and other Wnt antagonists to promote development of chordal and
prechordal mesoderm. N1 also synergized robustly with C1 and
other Wnt antagonists to induce ectopic heart formation in non-
cardiogenic mesoderm. These studies demonstrate that Dkk1 is a
dual-function protein and that the C1 and N1 domains activate
distinct signaling pathways. Since Dkk1 is not normally cleaved to
yield independent amino- and carboxyl terminal domains, we
propose that Wnt inhibition and the novel N1 activity are needed
in the intact protein for the normal induction of the heart and
anterior structures.
Materials and methods
Xenopus embryology, explant culture and histology
Embryos were fertilized in vitro, dejellied in 2% cysteine–HCl,
pH7.8, andmaintained in 0.1×MMR (Peng,1991) Embryos were staged
according to Nieuwkoop and Faber (1994). Dorsoanterior marginal
zone (DMZ) or ventroposterior marginal zone (VMZ) explants were
dissected at stage 10.25–10.5, when the blastopore was clearly
discernible. DMZ explants span the dorsoanterior 90° of the marginal
zone to include the presumptive heart ﬁeld and VMZ explants
comprise the ventroposterior 60° (Schneider and Mercola, 2001).
Dissections were performed in 0.75×MMR using a ﬁne tungsten
needle and processed immediately or cultured in 0.75×MMR until
sibling controls had reached appropriate stages. For animal cap
explants (prospective ectoderm), tissue approximately 30° from the
animal pole was dissected at stage 8 in 0.75×MMR.
Tissues were ﬂash frozen for subsequent RNA isolation or ﬁxed in
MEMPFA (1 M MOPS (pH 7.4), 20 mM EGTA, and 10 mM MgSO4) for
histological analyses. In situ hybridization was performed according
the protocol of Harland (1991). Digoxygenin-labelled probes were
transcribed from the following linearized plasmid templates (restric-
tion digest, polymerase): pCS2+-Shh (EcoRI, T3), pCS2+-XNot (HindIII,
T3), pGEM-XNkx2.5 (XbaI, T7), pXαMHC (HindIII, T7).
In some instances, explants after ﬁxation as above were processed
for whole mount immunostaining using the anti-cardiac Troponin-T
(cTn-T)monoclonal antibody (CT3, Developmental Studies Hybridoma
Bank, University of Iowa) and a Cy3-conjugated donkey anti-mouse
secondary antibody (Jackson ImmunoResearch Laboratories).
Plasmids and mRNA for injections
mRNA was transcribed from pCS2-tBMPR, pCS2-DKK1, pCS2-
Crescent, pCS2-WIF, pSP64T-Xwnt3a, pCS2BA-N1, and pCS2BA-C1
plasmids using SP6 mMessage mMachine kit (Ambion). pCS2BA-N1
and pCS2BA-C1 were constructed by moving previously described N1
and C1 sequences (Brott and Sokol, 2002) into an HA tag-containing
pCS2 vector. All cDNAs used encode Xenopus proteins except those for
Crescent (chick), Dkk1, C1 and N1 (all human). Injections were
performed in 3% Ficoll in 1×MMR (Peng, 1991). For VMZ experiments,
embryos were injected equatorially into the two ventral blastomeres
at 4–8 cell stage. For animal cap experiments, embryos were injected
into each blastomere at the 2-cell stage at the animal pole.
Quantiﬁcation of explant data and data presentation
Explants were stripped of identiﬁers and scored blindly for
phenotype (e.g. incidence of beating or marker expression). p-values
were calculated by the Chi-square test.Animal cap assays
Animal cap tissue (presumptive ectoderm) from injected (above)
or uninjected embryos was dissected at stage 8 and allowed to heal.
For measuring gene induction, tissues were processed for Q-RT-PCR
at stage 10. For cap elongation, Activin A (R&D Systems) in 0.75×MMR
and 1 mg/ml BSA was added during healing and caps were
photographedwhen sibling embryo controls reached stages 11 and 20.
Quantitative RT-PCR
10–12 explants were pooled from each round of injections and
RNAwas extracted using Qiagen RNeasy Lipid Tissue Kit (Qiagen). First
strand synthesis was carried out using a poly-dT primer and
Superscript II Reverse Transcriptase (Invitrogen). Real time RT-PCR
was performed on a Roche Light Cycler using the Light Cycler FastStart
DNA master SYBR Green I kit (Roche). Quantiﬁcation was carried out
by normalizing levels to amount of total cDNA using the ubiquitously
expressed EF1α transcript. The EF1α primer spans an intron and PCR
in the absence of RT thus conﬁrmed that RNA samples were free from
genomic DNA contamination. Experiments shown are representative
of a minimum of three RT-PCR experiments were performed and each
experiment included a minimum of three biological replicates. Inter-
experimental data were normalized to positive control samples
included in each experiment. Standard deviations of the combined
data set were calculated as described (Dixon and Massey, 1983).
Brieﬂy, for an n-experiment set, the square of standard deviation of
the mean for the set equals the sum of squares of standard deviation
for each experiment, divided by n2. p-values were calculated by
Student's T-test.
Primer pairs were: Chd forward 5′-AAC TGC CAG GAC TGG ATG GT-
3′, reverse 5′-GGC AGG ATT TAG AGT TGC TTC-3′ (Ta=62 °C) (Sasai et
al., 1994); Gsc forward 5′-GCT GAT TCC ACC AGT GCC TCA CCA G-3′,
reverse 5′-GGT CCT GTG CCT CCT CTT CCT CCT G-3′ (Ta=68 °C); ADMP
forward 5-GAT GAT GGA AGG AGA GGA-3′, reverse 5′-TCA TGT TCT
GAC CCA AAG-3′ (Ta=62 °C); Vent1 forward 5′-TTC CCT TCA GCA TGG
TTC AAC-3′, reverse 5′-GCA TCT CCT TGG CAT ATT TGG-3′ (Ta=58 °C)
(Sander et al., 2007); Vent2 forward 5′-GTT CTT TGG TGT GTA CGG-3′,
reverse 5′-GCA GGT AGA GCA TCT GAA-3′ (Ta=58 °C) (Nitta et al.,
2007); EF1α forward 5′-TAC CCT CCT CTT GGT CGT T-3′, reverse 5′-
GGT TTT CGC TGC TTT CTG-3′ (Ta=58 °C) (Foley and Mercola, 2005),
Xpo forward 5′-CCA CAG GTC CGA AGA G-3′, reverse 5′-TCC AGC AGA
GTG TCA T-3′ (Ta=60 °C); Xnr3 forward 5′-CGC TGG ACC TTG TTC TTT
G-3′, reverse 5′-GGG GGA TCA GGT TTA GCA T-3′ (Ta=60 °C); Tbx5
forward 5′-TAA GCA CCT ACA CGG C-3′, reverse 5′-ACC CAA CTC CGA
AGA C-3′ (Ta=60 °C).
Results
Novel signaling activity in the N-terminal domain of Dkk1
The dorsoanterior marginal zone (DMZ) of late blastula to early
gastrula-stage Xenopus embryos is characterized by low BMP and low
canonical Wnt signaling. Inhibition of these signaling pathways by
microinjection of synthetic mRNA encoding Dkk1 plus a truncated
form of the BMP receptor (tBR) into the prospective ventroposterior
marginal zone (VMZ) region of 4–8 cell embryos potently induces
complete secondary body axes (e.g. Glinka et al., 1998; Kazanskaya
and Nierhrs, 2000).
mRNAs for microinjection (Fig. 1A) were prepared to encode
isolated N1 and C1 domains, each with the native Dkk1 pro-region to
produce secreted proteins (Materials and methods). C1 in conjunc-
tion with tBR induced secondary axes (see below), consistent with
C1's Wnt inhibitory activity in a sensitive and quantitative Xsiamois
(Xsia) induction assay performed in animal caps (Fig. 1B). N1 lacked
any detectable ability to antagonize Wnt3a (Fig. 1B). Moreover, N1
Fig. 1. N1 lacks Wnt inhibitory activity but is active in secondary body axis induction. (A) Fragments of Dkk1 expressed by microinjection in this study (see Materials and methods).
(B) Xsia induction by Wnt3a in animal cap tissue following expression of N1 and C1 and assayed by quantitative real-time RT-PCR. N1 has b10−3-fold inhibitory activity relative to
C1. Similar results were obtained for Wnt8 (activity b10−2-fold relative to C1). Error bars indicate standard deviation (SD) and p-values were calculated by Students T-test [⁎, b0.01;
ns, not signiﬁcant (N0.05)]. (C) mRNAs were injected into the prospective VMZ region and embryos isolated at the neurula stage (stages 14–15). (D) In situ hybridization to Shh and
XNot to visualize prechordal (Shh) and chordal (Shh and XNot) mesoderm in the primary (black arrows) and secondary body axes (red arrows) induced by N1 in conjunction with
tBR. Class of secondary axes observed is indicated by: +/−, no or faint secondary axis; +, stronger staining but minimal anteriorwards extension; ++, strong staining, modest
anteriorwards extension, and +++, robust staining and extensive anteriorwards extension. Note that secondary axis Shh and XNot staining was broader and appeared disorganized
compared to the typically narrow pattern of the primary axis. For comparison, the inset shows an embryo with a secondary axis induced by Dkk1 plus tBR. (E) Quantiﬁcation of the
percentage of secondary axes induced according to class. p-values calculated by Chi-square test (⁎⁎, b0.001). Representative of 2 trials with similar outcomes.
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induce secondary body axes on its own (not shown), both in
agreement with a previous report (Brott and Sokol, 2002). Thus, N1
retains little if any canonical Wnt antagonizing activity and lacks
canonical Wnt signaling activity. Nonetheless, N1 showed a robust,
dose-dependent induction of head and axial mesoderm in secondary
body axes in the presence of tBR, as visualized by Sonic hedgehog
(Shh) and XNot positive cells at neurula stages (stages 14–15). The
secondary body axes were classiﬁed according to the anteriorwards
extent and strength of Shh or XNot gene expression (Fig. 1D) and
quantiﬁed by class. 80 pg of N1 mRNA yielded nearly maximal
induction of Shh (n=27) and XNot (n=20), respectively, comparable
to that achieved with similar amounts of C1, WIF-1, or Crescent (see
below).
To clarify how N1 induced secondary head and axial mesoderm,
we examined injected DMZ and VMZ tissues for changes in gene
expression by quantitative real-time reverse transcription polymer-
ase chain reaction (RT-PCR) as evidence of re-patterning by N1. In
contrast, N1 plus tBR injected into the VMZ signiﬁcantly increased
expression of the dorsoanterior genes Goosecoid (Gsc), Chordin (Chd),
and anti-dorsalizing morphogenetic protein (ADMP) over tBR alone(Fig. 2 right panels). These genes mark the early gastrula-stage (stage
10.5) DMZ (reviewed in De Robertis and Kuroda, 2004) and their
elevated expression is consistent with induction of chordal and
prechordal markers XNot and Shh in stage 14–15 embryos by N1 plus
tBR (Figs. 1D, E). N1 alone, however, failed to induce these
dorsoanterior genes. Expression of these genes reﬂects Nodal and
Smad2 signaling (Cho et al., 1991; Sander et al., 2007; Sasai et al.,
1994); thus, together with the inability of N1 to induce ectopic axes
when injected alone (not shown), we conclude that N1 alone is
unlikely to activate the Nodal pathway. We corroborated this
conclusion by showing that N1 alone did not induce cap elongation,
which is a classical readout of mesoderm-induction, nor did it
synergize with Activin A in this assay (Supplemental Fig. 1). N1 alone
or in conjunction with tBR did not induce Xenopus Nodal-related-3
(Xnr3) (Fig. 2, right bottom panel). N1 alone inhibited expression of
ventroposterior markers Vent1, Vent2 and Xenopus-posterior (Xpo) to
an extent comparable to that of tBR alone (Fig. 2 left panels). Taken
together, these results indicate that the N1 domain exerts a
dorsoanteriorizing inﬂuence prior to the onset of gastrulation but
does not appear to directly inﬂuence canonical Wnt or Nodal
pathways.
Fig. 2.N1 alters dorsoventral pattern before gastrulation. VMZ explants were dissected from embryos at onset of gastrulation (stage 10) and analyzed for ventroposterior (left panels)
or dorsoanterior (right panels) marker expression by quantitative real-time RT-PCR (Materials and methods). Ventroposterior and dorsoanterior marker gene expression levels were
normalized to uninjected VMZ or DMZ tissues, respectively. Experiments are the cumulative results of 3 independent experiments, eachwith at least 3 biological replicates. Error bars
indicate SD and p-values were calculated by Student's T-test. Note that N1 alone reduces expression of Xpo, Vent1 and Vent2 indicating a dorsoanteriorizing effect but that induction
of dorsoanterior markers Gsc, Chd, and ADMP occurs only in presence of tBR. Xnr3 is not induced by N1 either alone or with tBR.
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axial development
We next investigated whether N1 could synergize with C1 when
both were expressed as separate proteins. Complementarity in trans
would be consistent with the model that the two domains are capable
of signaling independently. As above, we scored secondary axes induced
by N1±C1,WIF or Crescent in the presence of tBR. As shown in Fig. 1, N1
alone in this assay induced a diffuse and poorly organized pattern of
Shh- and XNot-expressing tissue (Figs. 1D, E). C1 without N1 induced
Shh expression at neurula stages (stages 14–15; Figs. 3A, B) in a dose-
dependent manner. Despite apparent organization of Shh expression at
neurula stages, C1-induced secondary axes examined at approximately
stage 42 exhibited predominantly no eyes or cyclopia, at a dose of C1
(45 pg) selected to yield robust secondary body axes at high incidence
(100%, n=14) (Figs. 3C, D). Intact Dkk1 (50 pg, 100% secondary body
axes, n=15) typically had 2 eyes (Figs. 3C, D), supporting the view that
the C1 protein is deﬁcient relative to intact Dkk1 in stimulating
developmental processes, such as migration of head mesoderm or
induction of forebrain neurectoderm that normally split the single Xe-
nopus eye ﬁeld into two retinal primordia (Li et al., 1997).Notably, escalating doses of N1 mRNA injected together with a
constant submaximal dose of C1 (20 pg) resulted in a corresponding
increase in the extent and quality of the secondary body axes marked
by Shh (Fig. 3B). 20 pg (n=17) or 80 pg (n=18) of N1 mRNA directed
nearly all of the secondary axes (red arrows, Fig. 3A) to exhibit the
levels and anteriorwards extent of Shh expression seen in primary
axes (black arrows, Fig. 3A) or Dkk1-induced secondary axes (Fig. 1D
inset). Since N1without C1 produced poorly organized secondary axes
in this assay (Figs. 1D, E), we conclude that N1 can complement C1
plus tBR in trans.
Axial induction by the secreted Wnt antagonists WIF-1 and
Crescent was also potentiated by N1 (Figs. 3E–H). As with C1, 20 or
80 pg of N1 mRNA directed the Shh-expression pattern to match or
exceed that in the primary axes (n=30 and 20 for WIF-1 and
Crescent, respectively, for the 20 pg dose of N1; n=29 and 21 for
WIF-1 and Crescent, respectively for the 80 pg dose of N1). Since
WIF-1 and Crescent bind and sequester extracellular Wnt proteins
rather than bind LRP5/6 and Kremen (for review see Niehrs, 2006),
these results strongly indicate that the N1 domain within Dkk1 is
unlikely to function solely by modulating the efﬁcacy of C1, such as
by enhancing binding of C1 to LRP5/6 and disrupting the Wnt/
Fig. 3. N1 complements C1 and secreted Wnt antagonists in trans. A,B) Complementation of axial induction by C1. Embryos were injected as described in Fig. 1 with N1, C1 and tBR
mRNAs as indicated. In situ hybridization to Shh (A) revealed primary (black arrowheads) and secondary (red arrowheads) axes. The criteria used to score classes of secondary axes
are shown (A) and indicated by +/−, +, ++, and +++. Dose-dependence of secondary axis induction in response to C1 plus tBR and N1, C1 plus tBR is shown according to class (B). The
experiments using N1 and C1 are representative of 2 trials with similar outcomes; similar outcomes were also observed in additional experiments using 5 and 80 pg doses of C1. (C, D)
Examples of eye phenotype of secondary heads in embryos cultured until stage 45 (C). Quantiﬁcation of eye number in secondary axes of embryos injected with tBR, tBR and C1, and
tBR and Dkk1 (D). (E–H) Complementation of axial induction by WIF-1 (E, F) and Crescent (G, H) as in panels A, B. Note that complementation by N1 increases strength of axial
induction but retains characteristic pattern of induced Shh-expressing axial mesoderm. Thus, the criteria used to score secondary axes were stereotypical for each inducer (E, G).
Results showing complementarity are for 20 pg of Crescent andWIF-1; similar outcomes were observed in additional experiments using 5 and 80 pg doses of Crescent andWIF-1. p-
values were calculated by the Chi-square test [⁎⁎, b0.001; ⁎, b0.05; ns, not signiﬁcant (N0.05)].
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model that N1 provides an independent signal that is integrated at
another point in the signaling cascade, possibly at the level of
intracellular signaling.
Interestingly, C1, Crescent and WIF-1 each induced a characteristic
pattern of Shh-expressing chordomesodermal cells within the
secondary body axes (compare Figs. 3A, E, G). Identical results were
observed with XNot (not shown). The reason for the antagonist-
speciﬁc patterns is unclear but probably reﬂects differing abilities to
inhibit Wnt proteins present in the VMZ, including Wnts that signal
through canonical β-catenin as well as non-canonical pathways, and
differential patterning of head tissue (for instance, see Pera and De
Robertis, 2000; Wang et al., 1997). Notably, at these doses of Wnt
antagonists, N1 did not alter the pattern of Shh expression, but
potentiated the activity of the Wnt antagonist, providing further
evidence that N1 acts via a distinct signaling pathway from C1, WIF-1
and Crescent and that the signals are integrated in order to specify
secondary body axes.Novel heart-inducing activity of the Dkk1 N-terminal domain
Since the preceding experiments demonstrated that N1 is capable
of complementing the activity of Wnt antagonists in the speciﬁcation
of body axes induced in conjunction with tBR, we tested whether N1
also complements Wnt antagonists in the formation of hearts and
cement glands. As before, a constant dose of tBR and Crescent (Figs.
4A, C) or WIF-1 (Figs. 4B, D) mRNA was co-injected to induce a basal
incidence of 30–40% heart induction visible by αMHC expression in a
pattern similar to that of the native heart region in the primary body
axes. N1 alone did not induce αMHC+ heart tissue. In contrast, N1
robustly increased the frequency of αMHC+ heart tissue in a dose-
dependent manner, achieving ∼90% inductionwith 80 pg of N1mRNA
(n=16 for the 80 pg dose of N1 and 20 pg of both Crescent and WIF-1,
Figs. 4C, D).
In these embryos, N1 also increased the ability of WIF-1 plus tBR to
induce the cement gland, which is considered the most anterior head
structure in Xenopus embryos (Figs. 4B, E). Crescent plus tBR did not
Fig. 4. N1 synergizes with WIF-1 and Crescent to induce heart and cement gland. (A, B) Examples of embryos as in Fig. 3 cultured to stages 28–30 and stained by in situ
hybridization for αMHC to reveal developing myocardial tissue in primary (black arrow) and secondary (red arrow) body axes. N1 in conjunction with WIF-1, but not Crescent
increased the incidence of cement glands (green arrows). (C, D) Quantiﬁcation of the percentage of ectopic heart ﬁeld induced in response to N1 plus Crescent (C) or WIF-1 (D), and
according to class (−, +, ++, and +++) as in panels A and B. p-values were calculated by the Chi-square test [⁎⁎, b0.001; ⁎, b0.05; ns, not signiﬁcant (N0.05)]. Results showing
complementarity are for 20 pg of Crescent and WIF-1; similar outcomes were observed in additional experiments using 10 and 40 pg doses of both Crescent and WIF-1. (E)
Quantiﬁcation of the incidence of cement gland formation in response to WIF-1, N1 and tBR. N1 did not alter the lack of cement gland induction by Crescent and tBR (not shown,
but see text). ⁎⁎ indicates p-valueb0.001 as calculated by Student's T-test.
Fig. 5. N1 synergizes with Wnt antagonists directly to induce heart tissue. (A) Diagram of the VMZ explant assay. Isolated explants were cultured until stage 28 for analysis of Nkx2.5
and Tbx5 or stage 34 for αMHC expression by quantitative RT-PCR (B–D) or stage 40 for incidence of cTn-T+ explants by immunostaining (E, F). (B) N1 alone did not induce Nkx2.5,
Tbx5 or αMHC through a dose range of 38–600 pg of injected mRNA, whereas the native heart ﬁeld (HF) in DMZ explants expressed each marker as expected. (C, D) The effect of N1
plus a constant amount of C1 (C) or Crescent (D) on αMHC induction. The experiments are representative examples of at least 3 trials. E) Incidence of VMZ explants with ectopic
cTn-T+ myocardial tissue. p-values were calculated by the Chi-square test [⁎⁎, b0.001; ⁎, b0.05]. (F) Whole mount view of stage 40 VMZ explants immunostained with anti-cTn-T
showing that although N1 increased the incidence of cTn-T+ explants, they retained the small, dispersed foci characteristic of Crescent-induced myocardial tissue. Fluorescent image
(red) is superimposed on brightﬁeld image of explant.
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Fig. 6. Model for independent function of N1 and C1 in heart induction. C1 acts
indirectly by inhibiting Wnt signaling in the endoderm stimulate the production of a
diffusible intermediary that initiates cardiogenesis in mesoderm (Foley and Mercola,
2005). N1 might act on endoderm or directly on cardiogenic mesoderm (see text).
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increased but did not qualitatively alter the Shh pattern induced by
eachWnt antagonist, N1 combinedwith Crescent plus tBR also did not
induce cement glands, despite an increase in heart formation (Fig. 4C).
This reinforces the conclusion that N1 signals through a distinct
pathway that is integrated with Wnt antagonism.
We next tested heart induction in a more direct assay that does not
require tBR but instead evaluates the ability of a Wnt antagonist to
directly respecify non-cardiogenic VMZ to form heart tissue (dia-
grammed in Fig. 5A). Dkk1 mRNA injected in prospective VMZ at the
4–16 cell stage potently re-speciﬁes early gastrula-stage (stages 10–
10.5) VMZ explants, so that they will form a cyst-like structure
containing a rhythmically beating myocardial tube connected to
residual endoderm when maintained in explant culture (Schneider
and Mercola, 2001).
N1 alone did not induce ectopic hearts in the VMZ explant assay at
any dose tested in numerous trials (up to 600 pg, Fig. 5B). 200 pg of C1
induced αMHC in VMZ explants but addition of increasing amounts of
N1 robustly increased cardiomyogenic gene expression Fig. 5C).
Similarly, escalating doses of N1 synergized with 340 pg of Crescent
mRNA to induce αMHC (Fig. 5D). As an independent measure of
induction, the incidence of explants that stained positively for cardiac
troponin-T (cTn-T) was signiﬁcantly increased by N1 plus Crescent
relative to Crescent alone (Fig. 5E). However, the pattern of cTn-T
immunostaining in N1 plus Crescent injected explants were small and
isolated, characteristic of Crescent alone in contrast to the single heart
tubes typically induced by intact Dkk1 (Fig. 5F).
Discussion
Our results indicate that the amino terminal cysteine-rich region of
Dkk1 elicits a novel signaling response that complements axial and
heart inductive properties of canonical Wnt antagonists. Our data
indicate that synergy between the signal transduction pathways
activated by the N- and C-terminal regions contributes to the potency
of Dkk1 in the induction of prechordal and chordal mesoderm as well
as heart tissue. We did not detect any cleavage of the intact protein in
vivo (not shown) nor are we aware of any reports of endogenous
cleavage of Dkk1; thus, although the isolated N1 protein is functional,
we favor the model that the N- and C-terminal regions function in the
context of the intact protein (Fig. 6). We cannot rule out the possibility,
however, that Dkk1 might be cleaved to release a functional N1
protein in certain normal or pathological conditions, and it is notable
that cleavage of Dkk2 and Dkk4 into C-terminal and N-terminal
domains has been reported in cell culture preparations (Krupnik et al.,
1999).
Interestingly, although N1 robustly synergized with C1 as well as
naturally occurring, secreted Wnt antagonists to induce axial and
heart tissue, the qualitative pattern of Shh expression (Figs. 3A, E, G) or
the pattern of cTn-T+ myocardial tissue in VMZ explants (Fig. 5F)
remained as induced by the elevated doses of each of the individual
Wnt antagonists. These observations, coupled with the inability to
block Wnt signaling (Fig. 1B) suggest that N1 and C1 bind to distinct
receptors and that signaling is integrated distally, perhaps at the level
of intracellular mediators. A potentially related issue is that although
the heart-inducing potency of Dkk1 could be reconstituted by co-
expression of N1 and Wnt antagonists (Figs. 5C–E), the typical heart
morphogenesis apparent with Dkk1 was not reproduced by co-
injection of N1 with Wnt antagonists (e.g. Crescent, Fig. 5F),
suggesting that physically tethering the two activities protein might
be biologically important.
Dkk1, 2 and 4 function by binding LRP5/6, thereby disrupting the
canonical receptor–ligand signaling complex and also participates in
the downregulation of Kremen proteins from the cell surface (Niehrs,
2006). Whether the N-terminal domains of other Dkk proteins also
have similar or other activities is under investigation. Moreover, sinceLRP5/6 are required for canonical Wnt signaling, Dkk1, 2 and 4 differ
from other Wnt antagonists by biasing the composition of Wnt
receptors on the cell surface in favor of Frizzled receptors, which also
initiate non-canonical signaling and this mechanism is likely to
contribute to the observed stimulation of Jun kinase (JNK) activity by
Dkk1 during development and disease (Caneparo et al., 2007; Lee et
al., 2004; Pandur et al., 2002; Peng et al., 2006). Caneparo et al.
recently reported that the heparin sulfate proteoglycan Kynpek
synergizes with Dkk1 to activate JNK (Caneparo et al., 2007). It will
be important to determine the speciﬁc receptor(s) for N1 and its
intracellular mediators.
Finally, Dkk1 is involved in many natural embryological processes
in addition to the early axial and heart development addressed in this
paper, as well as in pathological settings as diverse as tumorigenesis
(for example Qian et al., 2007; Voorzanger-Rousselot et al., 2007;
Yamabuki et al., 2007) and rheumatoid arthritis (Diarra et al., 2007). It
will be important to evaluate the inﬂuence that N1 might have in
these settings, as well as in processes that have been examined
experimentally using recombinant Dkk1 as a reagent to disrupt Wnt
signaling.
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